Post cardiac arrest syndrome care pathway

WikiDoc Resources for Post cardiac arrest syndrome care pathway
Articles
Most recent articles on Post cardiac arrest syndrome care pathway Most cited articles on Post cardiac arrest syndrome care pathway Review articles on Post cardiac arrest syndrome care pathway Articles on Post cardiac arrest syndrome care pathway in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Post cardiac arrest syndrome care pathway Images of Post cardiac arrest syndrome care pathway Photos of Post cardiac arrest syndrome care pathway Podcasts & MP3s on Post cardiac arrest syndrome care pathway Videos on Post cardiac arrest syndrome care pathway
Evidence Based Medicine
Cochrane Collaboration on Post cardiac arrest syndrome care pathway Bandolier on Post cardiac arrest syndrome care pathway TRIP on Post cardiac arrest syndrome care pathway
Clinical Trials
Ongoing Trials on Post cardiac arrest syndrome care pathway at Clinical Trials.gov Trial results on Post cardiac arrest syndrome care pathway Clinical Trials on Post cardiac arrest syndrome care pathway at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Post cardiac arrest syndrome care pathway NICE Guidance on Post cardiac arrest syndrome care pathway NHS PRODIGY Guidance FDA on Post cardiac arrest syndrome care pathway CDC on Post cardiac arrest syndrome care pathway
Books
Books on Post cardiac arrest syndrome care pathway
News
Post cardiac arrest syndrome care pathway in the news Be alerted to news on Post cardiac arrest syndrome care pathway News trends on Post cardiac arrest syndrome care pathway
Commentary
Blogs on Post cardiac arrest syndrome care pathway
Definitions
Definitions of Post cardiac arrest syndrome care pathway
Patient Resources / Community
Patient resources on Post cardiac arrest syndrome care pathway Discussion groups on Post cardiac arrest syndrome care pathway Patient Handouts on Post cardiac arrest syndrome care pathway Directions to Hospitals Treating Post cardiac arrest syndrome care pathway Risk calculators and risk factors for Post cardiac arrest syndrome care pathway
Healthcare Provider Resources
Symptoms of Post cardiac arrest syndrome care pathway Causes & Risk Factors for Post cardiac arrest syndrome care pathway Diagnostic studies for Post cardiac arrest syndrome care pathway Treatment of Post cardiac arrest syndrome care pathway
Continuing Medical Education (CME)
CME Programs on Post cardiac arrest syndrome care pathway
International
Post cardiac arrest syndrome care pathway en Espanol Post cardiac arrest syndrome care pathway en Francais
Business
Post cardiac arrest syndrome care pathway in the Marketplace Patents on Post cardiac arrest syndrome care pathway
Experimental / Informatics
List of terms related to Post cardiac arrest syndrome care pathway

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S; Lakshmi Gopalakrishnan, M.B.B.S

A Complete List of What to Do

A. Initial Data Gathering (after ABC’s are stabilized)

1. History:

• Review

• eligibility
• contraindications
• advance directives
• overall prognosis

• Discuss issues with health care proxy, if available

2. Physical: Baseline Neurological Evaluation

• Exclude other causes of coma

• mass lesions
• Metabolic coma
• Seizures

• Document Glasgow Motor Score

3. Initial laboratories:

• Arterial blood gas
• CBC
• Platelets
• PT
• PTT
• P7 and Calcium
• Mg
• Phosphate
• Lactate
• CPK-MB
• Troponin
• Cortisol level
• Pan-culture
• Toxicology screen if appropriate

4. Serial laboratories:

• ScvO2 q 6 if PreSEP catheter not used
• Glucose (q 6 hrs x 2 days)
• Potassium q (6 hrs x 2 days)
• Lactate (q 6 hrs x 2 days)
• Repeat CPK-MB and Troponin at 6 hrs
• CBC (q 12 hr x 4)
• Platelets (q 12 hr x 4)
• PT (q 12 hr x 4)
• PTT (q 12 hr x 4)
• P7 (q 12 hr x 4)
• BUN (q 12 hr x 4)
• Creatinine (q 12 hr x 4)
• Calcium (q 12 hr x 4)
• Magnesium (q 12 hr x 4)
• Phosphate (q 12 hr x 4)

5. Chest X-Ray

• Chest x-rays are essential to rule out aspiration pneumonias and other underlying (possible) pulmonary pathologies.

6. Cranial CT:

• Rule out intracranial hemorrhage

7. Consultations:

Cardiology in all cases. Note: If cardiac catheterization is indicated, hypothermia should not be delayed.

8. Echocardiogram:

To r/o regional wall motion abnormality and severe contractile dysfunction.

B. Establish Appropriate Monitoring Immediately:

1. Cardiovascular:

• EKG after initial stabilization and repeat q 8 hours x 2 and prn to r/o acute coronary syndrome
• Arterial-line for continuous arterial blood pressure monitoring (essential prior to initiating hypothermia). Attempt radial artery x 1 and then proceed to femoral artery if necessary.
• Temperature monitoring Foley for continuous urine output and temperature monitoring. If there is no urine output, use an alternative site for temperature measurement – (e.g. esophageal)
• Presep catheter or other central venous catheters for central venous pressure & ScvO2 (subclavian site preferred) though don't delay hypothermia to perform this.

2. Pulmonary:

Continuous SaO2 probe, frequent ABG’s (use temperature correction)

3. Temperature:

Foley with temperature probe (use alternative site if no urine output)

4. Neurologic:

• Continuous EEG monitoring beginning within 6-12 hrs while paralyzed.
• Once in ICU, use BIS monitor to titrate sedation (40-60)
• Neuro checks q 2 hour (while paralyzed follow pupils and titrate paralysis per NMB Nursing Policy)

5. Additional monitoring and follow-up studies

• If net fluid balance is > 5 liters in 24 hrs, monitor intrabdominal pressure (IAP) via Foley catheter after cooling device has been discontinued (call medical resident if IAP is ≥ 20 mmHg).
• Consider to repeat echocardiogram 24-48 hours after return of spontaneous circulation
• Repeat Chest X-ray in AM and after 72 hours to rule out aspiration pneumonia

C. Initiate Appropriate Interventions

NOTE: Interventions should be carried out simultaneously when appropriate and feasible

• Post-Cardiac Arrest Early Goal-Directed Therapy
• Therapeutic hypothermia (if indicated)

• Treat acute coronary syndrome
• Treat hyperglycemia
• Antibiotic prophylaxis
• Fever prophylaxis
• Other ICU protocols if necessary

Therapeutic hypothermia

Main article: Therapeutic hypothermia

• Hypothermia activates the sympathetic nervous system causing vasoconstriction and shivering. Shivering increases O₂ consumption by 40-100%. Sedatives, opiates, and neuromuscular blockers can counteract these responses and enhance the effectiveness of active cooling. However, initiating paralysis in a patient that is already hypothermic should be avoided because it can result in a precipitous drop in core body temperature. Elderly patients will cool more quickly than younger or obese patients.
• Hypothermia shifts the oxyhemoglobin curve to the left may result in decreased O2 delivery. However, the metabolic rate is also lowered, decreasing O2 consumption / CO2 production, cardiac output and cerebral blood flow. Ventilator settings may need to be adjusted due to decreased CO2 production, using temperature corrected blood gases.
• Hypothermia initially causes sinus tachycardia, then bradycardia. With temp <30º C there is an increased risk for arrhythmias. With temp <28º C there is an increased risk for ventricular fibrillation. The severely hypothermic myocardium (<30°C) is less responsive to defibrillation and medications. Therefore it is extremely important to keep temp >30ºC.
• Hypothermia can induce coagulopathy which is treatable with platelets and FFP.
• Hypothermia-induced diuresis is to be expected and should be treated aggressively with fluid and electrolyte repletion. Magnesium, phosphorus and potassium should be monitored closely and maintained in the normal (because it will rebound to very high) range. Hypothermia commonly causes hypokalemia, which may be exacerbated by insulin administration for hyperglycemia. Conversely, when patients are re-warmed, potassium exits cells, and hyperkalemia may occur. Both hypokalemia hyperkalemia should be treated when they occur.
• Decreased insulin secretion and sensitivity leads to hyperglycemia, which should be treated aggressively.
• Re-warming too rapidly can cause vasodilation, hypotension, and rapid electrolyte shifts.

Eligibility Criteria for Post-Cardiac Arrest Therapeutic Hypothermia

• Meets eligibility criteria for Post-Cardiac Arrest Care Pathway
• Comatose at enrollment with a Glasgow Coma Motor Score <6 pre-sedation (i.e., patient doesn’t follow commands)
• No other obvious reasons for coma
• No uncontrolled bleeding
• Hemodynamically stable with no evidence of:

• Uncontrollable dysrhythmias
• Severe cardiogenic shock
• Refractory hypotension (MAP <60 mm Hg) despite preload optimization and use of vasoactive medications

• No existing, multi-organ dysfunction syndrome, severe sepsis, or comorbidities with minimal chance of meaningful survival independent of neurological status

Relative Contraindications for Therapeutic Hypothermia:

• Prolonged arrest time (> 60 minutes)
• Thrombocytopenia or other coagulopathies
• Pregnancy (Therapeutic hypothermia can potentially be performed on pregnant female in consultation with OB/Gyn)

Guidelines for Therapeutic Hypothermia

Preparation:

If criteria are met, the patient is cooled using the induced hypothermia protocol for 24 hours to a goal temperature of 32-34° C (89-93° F). The patient should be cooled to the target temperature as quickly as possible. The 24-hour time period is from the time of initiation of cooling

1. Place arterial line for blood pressure monitoring.
2. A continuous temperature monitor with bladder probe or esophageal catheter will aid in cooling process and prevents overcooling.
3. Use of secondary temperature device (Exergen) is also recommended to monitor temperature as bladder probe is accurate only if there is adequate urine output. This alternative temperature probe can be any core temperature monitor that is compatible with the Arctic Sun console.

External cooling with cooling blankets and ice:

1. Eligibility should be confirmed and materials should be gathered.
2. Obtain two cooling blankets and cables (one machine) to sandwich the patient between them. Each blanket should be covered with a sheet to protect the patient’s skin.
3. Cisatracurium (Nimbex) should be administered via microinfusion for paralysis. Bolus of 150mcg/kg and a maintenance dose of 2mcg/kg/min is used. Use of BIS or train of four are not recommended.
4. Propofol (Diprivan) or Midazolam (Versed) to be administered for sedation. Propofol- Bolus (optional) 0.3-0.5mg/kg followed by infusion of 1mg/kg/hour while patient is paralyzed. Midazolam- Bolus (optional) 0.05mg/kg followed by infusion of 0.125mg/kg/hour.
5. Pack the patient in ice (groin, axilla, side of neck and chest) and additional measures can also be used as needed to achieve the target temperature. Packing ice on top of chest should be avoided as ventilation may be impaired.
6. Cold saline infusion via a peripheral line or femoral venous catheter (NOT via jugular or subclavian line) can be performed to assist in achieving target temperature. 30cc/kg of 4°C normal saline over 30minutes..
7. Monitor vitals with attention towards arrhythmia detection.
8. Ice bags should be removed once target temperature is reached and the temperature should be maintained using cooling blankets.

External cooling with Arctic Sun Vest Device:

1. Eligibility should be confirmed and materials should be gathered.
2. Patient’s temperature should be noted and cooling pads should be placed on patient as per manufacturer’s guidelines.
3. Set target temperature after applying pads.
4. Sedate and paralyze the patient with agents mentioned above to control shivering.
5. External pacing pads can also be used with these pads. Place external pacing pads on the chest and cover with Arctic Sun pads.
6. Rewarming strategies as mentioned below.

Supportive Therapy

1. A mean arterial pressure (MAP) of more than 90mm of Hg is preferred for cerebral perfusion. In addition to hypothermia, hypertension improves neuroprotection. Target MAP should be determined by the treating physician taking into account the cardiac safety and advantage of higher cerebral perfusion pressures.
2. Monitor the patient for arrhythmias. Active cooling should be discontinued and actively re-warmed when significant dysrhythmias, hemodynamic instability or bleeding develops.
3. Electrolyte panel, glucose and complete blood count should be measured at 12hours and 24hours.
4. Arterial blood gases should be mkeasured at the patient's actual body temperature. CO2 should be maintained in the normal range (35-45).
5. Blood cultures should be drawn at 12 hours after the initiation of cooling as infections will be masked during the cooling phase.
6. Skin should be checked every 2 hours for burns caused by cold blankets. If the Arctic Sun device is utilized, skin should be checked every 6 hours.
7. Using a secondary temperature monitoring device when using the Arctic Sun is recommended. The patient temperature on the Arctic Sun, the secondary temperature source and the water temperature of the Arctic Sun are recorded. The water temp will help to determine the work of the machine in trying to maintain target temperature.

Re-warming

This is the most critical phase, as the previously constricted peripheral beds start to dilate with resultant hypotension as mentioned above.

Re-warming of the patient is begun 24hours after the initiation of cooling. It is recommended that the body be re-warmed at the rate of 0.5-1ºC every hour, thereby approximately 8-12hrs to passively re-warm up to a target temperature of 36ºC (96.8ºF).

Re-warming phase is a total of 72 hours, with passive re-warming for 24hours and controlled re-warming for 48hours.

Passive Re-warming:

At 24 hours (after the initiation of cooling) -

1. Remove cooling blankets (and ice if still in use).
2. Paralysis and sedation must be maintained until target temperature of 36ºC is reached: paralysis is discontinued first followed by midazolam once train of 4 is achieved.
3. Monitor patient for hypotension related to re-warming.
4. Monitor patient for hyperkalemia during re-warming.

Controlled Re-warming: If the Arctic Sun cooling vest is used, program the machine for controlled rewarming over 6-8hours. Dial the desired warming on the machine to maintain a target temperature for the next 48 hours.

The patient should be on constant follow-up with the stroke service to reassess the neurological status after the discontinuation of hypothermia.

See also

• Sudden cardiac death
• Sudden cardiac death post arrest care and prevention

• Post cardiac arrest syndrome care pathway

• Therapeutic hypothermia

External Links

• Therapeutic hypotermia trial at Clinical Trials.gov